Build Your Comparison

Side-by-side financial analysis
OMI logo
OMI
MCK logo
MCK
JPM logo
JPM
Try popular comparisons:

Stock Comparison

OMI vs MCK vs JPM

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
OMI
Owens & Minor, Inc.

Medical - Distribution

HealthcareNYSE • US
Market Cap$171M
5Y Perf.-70.6%
MCK
McKesson Corporation

Medical - Distribution

HealthcareNYSE • US
Market Cap$90.23B
5Y Perf.+441.8%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$908.57B
5Y Perf.+225.2%

OMI vs MCK vs JPM — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
OMI logoOMI
MCK logoMCK
JPM logoJPM
IndustryMedical - DistributionMedical - DistributionBanks - Diversified
Market Cap$171M$90.23B$908.57B
Revenue (TTM)$2.76B$403.43B$280.33B
Net Income (TTM)$-1.10B$4.76B$57.05B
Gross Margin3.6%60.0%
Operating Margin1.0%1.6%25.9%
Forward P/E2.3x17.0x14.6x
Total Debt$320M$8.61B$942.38B
Cash & Equiv.$282M$3.98B$343.34B

OMI vs MCK vs JPMLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

OMI
MCK
JPM
StockJun 20Feb 26Return
Owens & Minor, Inc. (OMI)10029.4-70.6%
McKesson Corporation (MCK)100541.8+441.8%
JPMorgan Chase & Co. (JPM)100325.2+225.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: OMI vs MCK vs JPM

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: MCK and JPM are tied at the top with 3 categories each — the right choice depends on your priorities. JPMorgan Chase & Co. is the stronger pick specifically for profitability and margin quality and capital preservation and lower volatility. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
OMI
Owens & Minor, Inc.
The Value Play

OMI is the clearest fit if your priority is value.

  • Lower P/E (2.3x vs 17.0x)
Best for: value
MCK
McKesson Corporation
The Growth Play

MCK has the current edge in this matchup, primarily because of its strength in growth exposure.

  • Rev growth 12.4%, EPS growth 49.2%, 3Y rev CAGR 13.4%
  • 12.4% revenue growth vs OMI's -74.2%
  • 0.4% yield, 18-year raise streak, vs JPM's 1.8%, (1 stock pays no dividend)
Best for: growth exposure
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM is the clearest fit if your priority is income & stability and long-term compounding.

  • Dividend streak 15 yrs, beta 0.87, yield 1.8%
  • 481.2% 10Y total return vs MCK's 328.4%
  • Lower volatility, beta 0.87, current ratio 0.52x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthMCK logoMCK12.4% revenue growth vs OMI's -74.2%
ValueOMI logoOMILower P/E (2.3x vs 17.0x)
Quality / MarginsJPM logoJPM20.4% margin vs OMI's -39.8%
Stability / SafetyJPM logoJPMBeta 0.87 vs OMI's 1.41
DividendsMCK logoMCK0.4% yield, 18-year raise streak, vs JPM's 1.8%, (1 stock pays no dividend)
Momentum (1Y)JPM logoJPM+20.9% vs OMI's -70.0%
Efficiency (ROA)MCK logoMCK5.7% ROA vs OMI's -44.9%, ROIC 254.1% vs 1.8%

OMI vs MCK vs JPM — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

OMIOwens & Minor, Inc.
FY 2025
Diabetes Product
56.9%$783M
Product and Service, Other
20.9%$288M
Wound Care
13.7%$189M
Urology
8.4%$116M
MCKMcKesson Corporation
FY 2026
North American Pharmaceutical Segment
83.4%$336.7B
Oncology And Multispecialty Segment
12.0%$48.4B
Medical-Surgical Solutions Segment
2.9%$11.5B
Prescription Technology Solutions Segment
1.4%$5.8B
Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment
0.3%$1.0B
JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000

OMI vs MCK vs JPM — Financial Metrics

Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLJPMLAGGINGMCK

Income & Cash Flow (Last 12 Months)

JPM leads this category, winning 4 of 6 comparable metrics.

MCK is the larger business by revenue, generating $403.4B annually — 146.1x OMI's $2.8B. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to OMI's -39.8%. On growth, MCK holds the edge at +6.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricOMI logoOMIOwens & Minor, In…MCK logoMCKMcKesson Corporat…JPM logoJPMJPMorgan Chase & …
RevenueTrailing 12 months$2.8B$403.4B$280.3B
EBITDAEarnings before interest/tax$277M$7.1B$81.4B
Net IncomeAfter-tax profit-$1.1B$4.8B$57.0B
Free Cash FlowCash after capex-$353M$5.9B$100.9B
Gross MarginGross profit ÷ Revenue+3.6%+60.0%
Operating MarginEBIT ÷ Revenue+1.0%+1.6%+25.9%
Net MarginNet income ÷ Revenue-39.8%+1.2%+20.4%
FCF MarginFCF ÷ Revenue-12.8%+1.5%+36.0%
Rev. Growth (YoY)Latest quarter vs prior year-146.3%+6.0%
EPS Growth (YoY)Latest quarter vs prior year+4.5%+37.0%+16.0%
JPM leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

OMI leads this category, winning 4 of 5 comparable metrics.

At 16.2x trailing earnings, JPM trades at a 17% valuation discount to MCK's 19.6x P/E. On an enterprise value basis, OMI's 1.7x EV/EBITDA is more attractive than JPM's 18.5x.

MetricOMI logoOMIOwens & Minor, In…MCK logoMCKMcKesson Corporat…JPM logoJPMJPMorgan Chase & …
Market CapShares × price$171M$90.2B$908.6B
Enterprise ValueMkt cap + debt − cash$209M$94.9B$1.51T
Trailing P/EPrice ÷ TTM EPS-0.16x19.56x16.22x
Forward P/EPrice ÷ next-FY EPS est.2.31x16.96x14.60x
PEG RatioP/E ÷ EPS growth rate0.92x
EV / EBITDAEnterprise value multiple1.70x13.21x18.52x
Price / SalesMarket cap ÷ Revenue0.06x0.22x3.25x
Price / BookPrice ÷ Book value/share2.51x
Price / FCFMarket cap ÷ FCF15.78x9.01x
OMI leads this category, winning 4 of 5 comparable metrics.

Profitability & Efficiency

MCK leads this category, winning 5 of 8 comparable metrics.

JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-21 for OMI. On the Piotroski fundamental quality scale (0–9), MCK scores 7/9 vs OMI's 2/9, reflecting strong financial health.

MetricOMI logoOMIOwens & Minor, In…MCK logoMCKMcKesson Corporat…JPM logoJPMJPMorgan Chase & …
ROE (TTM)Return on equity-21.1%+15.9%
ROA (TTM)Return on assets-44.9%+5.7%+1.3%
ROICReturn on invested capital+1.8%+2.5%+4.5%
ROCEReturn on capital employed+1.3%+44.8%+8.9%
Piotroski ScoreFundamental quality 0–9275
Debt / EquityFinancial leverage2.60x
Net DebtTotal debt minus cash$38M$4.6B$599.0B
Cash & Equiv.Liquid assets$282M$4.0B$343.3B
Total DebtShort + long-term debt$320M$8.6B$942.4B
Interest CoverageEBIT ÷ Interest expense-0.12x51.78x0.74x
MCK leads this category, winning 5 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

JPM leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in MCK five years ago would be worth $41,282 today (with dividends reinvested), compared to $514 for OMI. Over the past 12 months, JPM leads with a +20.9% total return vs OMI's -70.0%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.7% vs OMI's -50.9% — a key indicator of consistent wealth creation.

MetricOMI logoOMIOwens & Minor, In…MCK logoMCKMcKesson Corporat…JPM logoJPMJPMorgan Chase & …
YTD ReturnYear-to-date-3.4%-8.6%+0.8%
1-Year ReturnPast 12 months-70.0%+3.4%+20.9%
3-Year ReturnCumulative with dividends-88.2%+85.0%+138.8%
5-Year ReturnCumulative with dividends-94.9%+312.8%+135.5%
10-Year ReturnCumulative with dividends-87.3%+328.4%+481.2%
CAGR (3Y)Annualised 3-year return-50.9%+22.8%+33.7%
JPM leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — MCK and JPM each lead in 1 of 2 comparable metrics.

MCK is the less volatile stock with a -0.11 beta — it tends to amplify market swings less than OMI's 1.41 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 96.2% from its 52-week high vs OMI's 23.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricOMI logoOMIOwens & Minor, In…MCK logoMCKMcKesson Corporat…JPM logoJPMJPMorgan Chase & …
Beta (5Y)Sensitivity to S&P 5001.41x-0.11x0.87x
52-Week HighHighest price in past year$9.55$999.00$338.09
52-Week LowLowest price in past year$1.84$637.00$269.72
% of 52W HighCurrent price vs 52-week peak+23.5%+75.1%+96.2%
RSI (14)Momentum oscillator 0–10046.551.872.1
Avg Volume (50D)Average daily shares traded690K906K7.4M
Evenly matched — MCK and JPM each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — MCK and JPM each lead in 1 of 2 comparable metrics.

Analyst consensus: OMI as "Hold", MCK as "Buy", JPM as "Buy". Consensus price targets imply 596.4% upside for OMI (target: $16) vs 4.5% for JPM (target: $340). For income investors, JPM offers the higher dividend yield at 1.83% vs MCK's 0.41%.

MetricOMI logoOMIOwens & Minor, In…MCK logoMCKMcKesson Corporat…JPM logoJPMJPMorgan Chase & …
Analyst RatingConsensus buy/hold/sellHoldBuyBuy
Price TargetConsensus 12-month target$15.60$994.86$339.75
# AnalystsCovering analysts103161
Dividend YieldAnnual dividend ÷ price+0.4%+1.8%
Dividend StreakConsecutive years of raises01815
Dividend / ShareAnnual DPS$3.07$5.95
Buyback YieldShare repurchases ÷ mkt cap0.0%+5.3%+3.8%
Evenly matched — MCK and JPM each lead in 1 of 2 comparable metrics.
Key Takeaway

JPM leads in 2 of 6 categories (Income & Cash Flow, Total Returns). OMI leads in 1 (Valuation Metrics). 2 tied.

Best OverallJPMorgan Chase & Co. (JPM)Leads 2 of 6 categories
Loading custom metrics...

OMI vs MCK vs JPM: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is OMI or MCK or JPM a better buy right now?

For growth investors, McKesson Corporation (MCK) is the stronger pick with 12.

4% revenue growth year-over-year, versus -74. 2% for Owens & Minor, Inc. (OMI). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 2x trailing P/E (14. 6x forward), making it the more compelling value choice. Analysts rate McKesson Corporation (MCK) a "Buy" — based on 31 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — OMI or MCK or JPM?

On trailing P/E, JPMorgan Chase & Co.

(JPM) is the cheapest at 16. 2x versus McKesson Corporation at 19. 6x. On forward P/E, Owens & Minor, Inc. is actually cheaper at 2. 3x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — OMI or MCK or JPM?

Over the past 5 years, McKesson Corporation (MCK) delivered a total return of +312.

8%, compared to -94. 9% for Owens & Minor, Inc. (OMI). Over 10 years, the gap is even starker: JPM returned +481. 2% versus OMI's -87. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — OMI or MCK or JPM?

By beta (market sensitivity over 5 years), McKesson Corporation (MCK) is the lower-risk stock at -0.

11β versus Owens & Minor, Inc. 's 1. 41β — meaning OMI is approximately -1354% more volatile than MCK relative to the S&P 500.

05

Which is growing faster — OMI or MCK or JPM?

By revenue growth (latest reported year), McKesson Corporation (MCK) is pulling ahead at 12.

4% versus -74. 2% for Owens & Minor, Inc. (OMI). On earnings-per-share growth, the picture is similar: McKesson Corporation grew EPS 49. 2% year-over-year, compared to -201. 1% for Owens & Minor, Inc.. Over a 3-year CAGR, MCK leads at 13. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — OMI or MCK or JPM?

JPMorgan Chase & Co.

(JPM) is the more profitable company, earning 20. 4% net margin versus -39. 8% for Owens & Minor, Inc. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus 1. 0% for OMI. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is OMI or MCK or JPM more undervalued right now?

On forward earnings alone, Owens & Minor, Inc.

(OMI) trades at 2. 3x forward P/E versus 17. 0x for McKesson Corporation — 14. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OMI: 596. 4% to $15. 60.

08

Which pays a better dividend — OMI or MCK or JPM?

In this comparison, JPM (1.

8% yield), MCK (0. 4% yield) pay a dividend. OMI does not pay a meaningful dividend and should not be held primarily for income.

09

Is OMI or MCK or JPM better for a retirement portfolio?

For long-horizon retirement investors, McKesson Corporation (MCK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

11), +328. 4% 10Y return). Both have compounded well over 10 years (MCK: +328. 4%, OMI: -87. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between OMI and MCK and JPM?

These companies operate in different sectors (OMI (Healthcare) and MCK (Healthcare) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: OMI is a small-cap quality compounder stock; MCK is a mid-cap quality compounder stock; JPM is a large-cap deep-value stock. JPM pays a dividend while OMI, MCK do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.